| Utestående aktier | 5,726,750 shares |
| Insideraktier | 102 301 037 shares |
| Totalt antal insynspersoner | 19 |
Insider Sentiment Score
Insider sentiment score hittar de företag som köps av foretagsinsynspersoner.
Det är resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av insiderackumulation. Poängmodellen använder en kombination av nettoantalet insiders som köpt de föregående 90 dagarna, det totala antalet aktier som köpts i procent av aktiekapitalet och det totala antalet aktier som ägs av insiders. Siffran sträcker sig från 0 till 100, med högre siffror som indikerar en högre nivå av ackumulering för sina kamrater, och 50 är genomsnittet.
Uppdateringsfrekvens: Dagligen
Se Insiders Top Picks, som ger en lista över företag med högsta insiderackumulation.
Office Sentiment Score
Officersentiment Score hittar företag som köps av Corporate Officers.
Per definition Corporate Officers är Corporate Insiders, men till skillnad från vissa av de andra Insiders (10 % aktieägare och styrelseledamöter), arbetar ämbetsmän för företaget dagligen och de använder sina egna pengar när de handlar . (10 % aktieägare och styrelseledamöter är ofta fondförvaltare som förvaltar andras pengar.) Som sådan är insideraffärer som görs av tjänstemän mycket mer betydelsefulla och bör behandlas på lämpligt sätt.
Liksom Insider Sentiment Score är Officer Sentiment Score resultatet av en sofistikerad, kvantitativ multifaktormodell som identifierar företag med de högsta nivåerna av officersackumulering.
Uppdateringsfrekvens: Dagligen
Se insiderns bästa val, vilket ger en lista över företag med högsta insider sentiment.
Viktiga insidernyckeltal
Denna kort visar hur företaget rankas längs olika insidernyckeltal. Procenttilrankningen visar hur detta företag jämförs med andra företag på USA-marknaden. Högre rankingar indikerar bättre situationer.
Till exempel anses det allmänt att insiderköp är en positiv indikator, så företag med mer insiderköp skulle rankas högre än företag med mindre insiderköp (eller til och med insiderförsäljning).
Procent av flytande köpta av insiders (ranking)
0.000 %( )
9535 out of 11220Procentandelen av aktier köpta av insiders är det totala antalet aktier som köpts av insiders minus det totala antalet aktier som sålts av insiders under de senaste 90 dagarna, dividerat med det totala antalet aktier och multiplicerat med 100.
Insiderhandelsdiagram
Phio Pharmaceuticals Corp. insideraffärer visas i följande diagram. Insiders är tjänstemän, styrelseledamöter eller betydande investerare i ett företag. I allmänhet är det i allmänhet olagligt för insiders att göra affärer i sina företag baserat på väsentlig, icke-offentlig information. Detta betyder inte att det är olagligt för dem att göra några affärer i sina egna företag. De måste dock rapportera alla affärer till SEC via ett formulär 4.
Insiderlista och lönsamhetsstatistik
Den här tabellen visar listan över kända insiders och genereras automatiskt från anmälningar som avslöjas till SEC. Förutom namnen, den senaste titeln och direktören, tjänstemannen eller ägarbeteckningen på 10 %, tillhandahåller vi de senaste avslöjade innehaven. Dessutom, när det är möjligt tillhandahåller vi insiderns historiska handelsresultat. Det historiska handelsresultatet är ett vägt genomsnitt av resultatet för faktiska köptransaktioner på den öppna marknaden som insidern gjort. För mer information om hur detta beräknas, titta på detta YouTube-webinarium.
See our leaderboard of most profitable insider traders.
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Advanced RNA Technologies, LLC - | 1 221 723 | 1 221 723 | |
| Patricia A Bradford Director - [D] | 27 151 | 27 151 | |
| John A Barrett Chief Development Officer - [O] | 222 991 | 8 802 | |
| Robert J Bitterman Chairman, Pres. & CEO, Director - [D] [O] | 271 421 | 271 421 | |
| Keith L Brownlie Director - [D] | 20 000 | 789 | |
| Geert Cauwenbergh Director - [D] | 4 235 | 471 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Lisa Cabott Carson VP, Finance and Administration - [O] | 47 000 | 47 000 | |
| David H Deming Director - [D] | 14 000 | 14 000 | |
| Gerrit Dispersyn President & CEO, Director - [D] [O] | 212 327 | 20 222 | |
| Dorman H. Paul Director - [D] | 20 370 | 1 940 | |
| Alexey Eliseev Chief Business Officer - [O] | 950 312 | 950 312 | |
| Robert L Ferrara Director - [D] | 38 766 | 38 766 |
| Insider | Genomsnitt vinst (%) | Aktier Ägda |
Delad Justerad |
|---|---|---|---|
| Jonathan E Freeman Director - [D] | 16 055 | 16 055 | |
|
Galena Biopharma, Inc.
10% Owner -
|
32 393 095 | 32 393 095 | |
| Infarinato Robert M. VP, CFO - [O] | 11 000 | 11 000 | |
| Caitlin Kontulis Secretary & VP Finance & Admin - [O] | 10 643 | 1 183 | |
| Curtis Lockshin Director - [D] | 18 555 | 18 555 | |
|
Opko Health, Inc.
10% Owner -
|
67 241 380 | 67 241 380 | |
| Pamela Pavco Chief Development Officer - [O] | 17 173 | 17 173 |
Report errors via our new Insider Auditing Tool
Track Records av insiderköp - Kortsiktig vinstanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PHIO / Phio Pharmaceuticals Corp.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste köpen på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Track Records av insiderförsäljning - Kortsiktig förlustanalys
I denna sektion analyserar vi lönsamheten för varje oplanerat, öppet-marknads insiderköp gjorda i PHIO / Phio Pharmaceuticals Corp.. Denna analys hjälper till att förstå om insidern konsekvent genererar onormala avkastningar och är värd att följa. Denna analys är för ett år efter varje handel, och resultaten är teoretiska .
Tabellen nedan visar de senaste försäljningarna på öppna marknaden som inte var en del av en automatisk handelsplan.
Justeringar av aktierär de justerade aktierna efter justerat pris. Justeringar av aktierär de justerade aktierna efter uppdelning.
Transaktionshistorik
Klicka på länkikonen för att se hela transaktionshistoriken. Transaktioner som rapporteras som en del av en automatisk handelsplan 10b5-1 kommer att ha ett X i kolumnen markerad 10b-5.
| Fil datum |
Handel datum |
Schema | Insider | Ticker | Värdepappertitel | Kod | Direkta | Utövningspris | Enhet pris |
Enheter ändrad |
Värde ändrad (1K) |
Kvarvarande Optioner |
Kvarvarande Aktier |
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-09-15 | 2025-09-11 | 4/A | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23 100 | 38 766 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Deming David H | PHIO | Common Stock, $.0001 par value | D | 14 000 | 14 000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Ferrara Robert L | PHIO | Common Stock, $.0001 par value | D | 23 000 | 38 666 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $.0001 par value | D | 14 700 | 16 055 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $.0001 par value | D | 16 200 | 18 555 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $.0001 par value | D | 18 800 | 27 151 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Carson Lisa Cabott | PHIO | Common Stock, $.0001 par value | D | 47 000 | 47 000 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 250 000 | 271 421 | ||||||
| 2025-09-15 | 2025-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $.0001 par value | D | 2,3200 | −4 111 | −10 | 21 421 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 2,4199 | 2 500 | 6 | 15 666 | ||||
| 2025-06-11 | 2025-06-10 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,4200 | 2 000 | 5 | 27 149 | ||||
| 2025-06-10 | 2025-06-09 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 2,7500 | 1 500 | 4 | 25 149 | ||||
| 2025-05-23 | 2025-05-22 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7799 | 1 200 | 2 | 23 649 | ||||
| 2025-05-23 | 2025-05-21 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 1,7700 | 3 000 | 5 | 22 449 | ||||
| 2025-05-21 | 2025-05-20 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1,8200 | 2 500 | 5 | 13 166 | ||||
| 2024-09-13 | 2024-09-11 | 4 | Bitterman Robert J | PHIO | Common Stock, $0.0001 par value | D | 15 500 | 17 832 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Freeman Jonathan E | PHIO | Common Stock, $0.0001 par value | D | 1 000 | 1 000 | ||||||
| 2024-09-13 | 2024-09-11 | 4 | Infarinato Robert M. | PHIO | Common Stock, $0.0001 Par Value | D | 3 000 | 11 000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Lockshin Curtis | PHIO | Common Stock, $0.0001 par value | D | 2 000 | 2 000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | BRADFORD PATRICIA A | PHIO | Common Stock, $0.0001 par value | D | 8 000 | 8 000 | ||||||
| 2024-09-12 | 2024-09-11 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 000 | ||||||
| 2024-08-15 | 2024-08-13 | 4 | Infarinato Robert M. | PHIO | Common stock, $0.0001 par value | D | 8 000 | 8 000 | ||||||
| 2024-06-11 | 2024-06-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7400 | 1 000 | 1 | 20 990 | ||||
| 2024-06-10 | 2024-06-06 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7500 | 1 000 | 1 | 19 990 | ||||
| 2024-03-05 | 2024-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,9580 | −335 | −0 | 10 643 | ||||
| 2024-02-27 | 2024-02-26 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,9100 | 2 500 | 2 | 18 990 | ||||
| 2024-02-22 | 2024-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,7600 | −1 804 | −1 | 16 490 | ||||
| 2024-02-20 | 2024-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6600 | −523 | −0 | 10 978 | ||||
| 2024-02-20 | 2024-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,6500 | −658 | −0 | 11 501 | ||||
| 2023-10-03 | 2023-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 1,5100 | −917 | −1 | 18 294 | ||||
| 2023-07-05 | 2023-07-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8400 | 1 000 | 3 | 19 211 | ||||
| 2023-07-05 | 2023-06-30 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 2,8800 | 1 000 | 3 | 18 211 | ||||
| 2023-06-15 | 2023-06-14 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1000 | 2 000 | 6 | 6 000 | ||||
| 2023-03-03 | 2023-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,4900 | −335 | −2 | 12 159 | ||||
| 2023-02-22 | 2023-02-17 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 1 500 | 3 197 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 1 500 | 3 167 | ||||||
| 2023-02-22 | 2023-02-20 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 11 000 | 17 211 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 1 500 | 4 000 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 1 500 | 4 235 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 4 500 | 12 494 | ||||||
| 2023-02-22 | 2023-02-17 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 1 500 | 3 197 | ||||||
| 2023-02-17 | 2023-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 5,2000 | −657 | −3 | 7 994 | ||||
| 2022-12-15 | 2022-12-14 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2 000 | 1 | 74 541 | ||||
| 2022-12-08 | 2022-12-07 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,3900 | 2 000 | 1 | 72 541 | ||||
| 2022-12-06 | 2022-12-05 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4300 | 2 000 | 1 | 70 541 | ||||
| 2022-12-05 | 2022-12-02 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4082 | 5 000 | 2 | 30 000 | ||||
| 2022-11-29 | 2022-11-29 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4000 | 215 | 0 | 68 541 | ||||
| 2022-11-29 | 2022-11-25 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,4200 | 2 500 | 1 | 68 326 | ||||
| 2022-11-28 | 2022-11-23 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,4099 | 2 000 | 1 | 25 000 | ||||
| 2022-11-16 | 2022-11-16 | 4 | Bitterman Robert J | PHIO | Series D Preferred Stock, $0.0001 par value | D | 1 750,0000 | 1 | 2 | 1 | ||||
| 2022-10-03 | 2022-10-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 40 000 | 65 826 | ||||||
| 2022-09-26 | 2022-08-09 | 4 | BRADFORD PATRICIA A | PHIO | Common stock, $0.0001 par value | D | 20 000 | 20 000 | ||||||
| 2022-03-03 | 2022-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,8210 | −4 011 | −3 | 103 815 | ||||
| 2022-03-03 | 2022-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,8210 | −8 954 | −7 | 212 327 | ||||
| 2022-02-16 | 2022-02-15 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10 000 | 20 366 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 68 000 | 107 826 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10 000 | 20 364 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10 000 | 23 000 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10 000 | 20 370 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 126 000 | 221 281 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10 000 | 32 822 | ||||||
| 2022-02-16 | 2022-02-15 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10 000 | 25 826 | ||||||
| 2021-08-17 | 2021-08-16 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 1,6300 | 6 000 | 10 | 95 281 | ||||
| 2021-03-05 | 2021-03-04 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5600 | 1 953 | 5 | 89 281 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 10 000 | 15 826 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Freeman Jonathan E | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 364 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 3,1500 | 682 | 2 | 13 000 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 10 000 | 12 318 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Lockshin Curtis | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 366 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 10 000 | 22 822 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Dorman H. Paul | PHIO | Common stock, $0.0001 par value | D | 10 000 | 10 370 | ||||||
| 2021-03-03 | 2021-03-03 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 3,0300 | 2 500 | 8 | 87 328 | ||||
| 2021-03-03 | 2021-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 68 450 | 84 828 | ||||||
| 2021-03-03 | 2021-03-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 34 600 | 39 826 | ||||||
| 2020-08-19 | 2020-08-19 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,5000 | 2 000 | 5 | 16 377 | ||||
| 2020-03-03 | 2020-03-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 2,9300 | −673 | −2 | 14 628 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 237 500 | 24 | 279 030 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 350 000 | 35 | 827 817 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Bitterman Robert J | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 300 000 | 30 | 320 440 | ||||
| 2019-11-20 | 2019-11-18 | 4 | Ferrara Robert L | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 127 500 | 13 | 127 500 | ||||
| 2019-11-20 | 2019-11-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,1000 | 225 000 | 22 | 704 841 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Kontulis Caitlin | PHIO | Common stock, $0.0001 par value | D | 0,4030 | −749 | −0 | 41 530 | ||||
| 2019-08-02 | 2019-08-01 | 4 | Dispersyn Gerrit | PHIO | Common stock, $0.0001 par value | D | 0,4030 | −1 236 | −0 | 477 817 | ||||
| 2019-08-02 | 2019-08-01 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,4030 | −1 751 | −1 | 479 841 | ||||
| 2019-04-24 | 2019-04-22 | 4 | Barrett John A | PHIO | Common stock, $0.0001 par value | D | 222 991 | 222 991 | ||||||
| 2019-03-05 | 2019-03-01 | 4 | Dispersyn Gerrit | PHIO | Common Stock | D | 407 703 | 479 053 | ||||||
| 2019-03-01 | 2019-02-28 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3798 | 152 415 | 58 | 481 592 | ||||
| 2019-02-19 | 2019-02-15 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3634 | 22 279 | 8 | 329 177 | ||||
| 2019-02-15 | 2019-02-13 | 4 | Dorman H. Paul | PHIO | Common stock | D | 10 000 | 20 375 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Lockshin Curtis | PHIO | Common stock | D | 10 000 | 20 130 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Freeman Jonathan E | PHIO | Common stock | D | 10 000 | 20 000 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Dispersyn Gerrit | PHIO | Common stock | D | 55 000 | 71 350 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Kontulis Caitlin | PHIO | Common stock | D | 27 000 | 40 214 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Bitterman Robert J | PHIO | Common stock | D | 10 000 | 20 440 | ||||||
| 2019-02-15 | 2019-02-13 | 4 | Brownlie Keith L | PHIO | Common stock | D | 10 000 | 20 000 | ||||||
| 2019-02-04 | 2019-02-01 | 4 | CAUWENBERGH GEERT | PHIO | Common Stock, $0.0001 par value | D | 0,3771 | 21 470 | 8 | 306 898 | ||||
| 2019-01-22 | 2019-01-18 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3412 | 23 729 | 8 | 285 428 | ||||
| 2019-01-07 | 2019-01-04 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3499 | 23 139 | 8 | 261 699 | ||||
| 2018-12-26 | 2018-12-21 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,2950 | 27 445 | 8 | 238 560 | ||||
| 2018-12-10 | 2018-12-07 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3700 | 21 882 | 8 | 211 115 | ||||
| 2018-11-26 | 2018-11-23 | 4 | CAUWENBERGH GEERT | PHIO | Common stock, $0.0001 par value | D | 0,3121 | 25 941 | 8 | 189 233 | ||||
| 2018-11-13 | 2018-11-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4330 | 18 698 | 8 | 163 292 | ||||
| 2018-10-29 | 2018-10-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4372 | 18 519 | 8 | 144 594 | ||||
| 2018-10-15 | 2018-10-12 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4699 | 17 230 | 8 | 126 075 | ||||
| 2018-10-01 | 2018-09-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 73 587 | 86 | 108 845 | ||||
| 2018-08-03 | 2018-08-01 | 4 | Dorman H. Paul | RXII | Common Stock | D | 10 000 | 10 375 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Freeman Jonathan E | RXII | Common Stock | D | 10 000 | 10 000 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Lockshin Curtis | RXII | Common Stock | D | 10 000 | 10 130 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 1,79 | 10 500 | 10 500 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Kontulis Caitlin | RXII | Common Stock | D | 10 500 | 11 024 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 1,79 | 16 000 | 16 000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | Dispersyn Gerrit | RXII | Common Stock | D | 16 000 | 16 350 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 1,79 | 21 000 | 21 000 | |||||
| 2018-08-03 | 2018-08-01 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 21 000 | 35 258 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Bitterman Robert J | RXII | Common Stock | D | 10 000 | 10 440 | ||||||
| 2018-08-03 | 2018-08-01 | 4 | Brownlie Keith L | RXII | Common Stock | D | 10 000 | 10 000 | ||||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4500 | 7 100 | 3 | 142 583 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4600 | 200 | 0 | 135 483 | ||||
| 2017-10-02 | 2017-10-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4400 | 2 700 | 1 | 135 283 | ||||
| 2017-09-07 | 2017-09-07 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5283 | −58 712 | −31 | 950 312 | ||||
| 2017-09-07 | 2017-09-06 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5365 | −91 907 | −49 | 1 009 024 | ||||
| 2017-09-07 | 2017-09-05 | 4 | Eliseev Alexey | RXII | Common stock, par value $0.0001 | D | 0,5571 | −26 181 | −15 | 1 100 931 | ||||
| 2017-09-01 | 2017-09-01 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 0,5682 | −23 200 | −13 | 1 127 112 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5600 | 739 | 0 | 132 583 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5500 | 4 361 | 2 | 131 844 | ||||
| 2017-08-24 | 2017-08-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,5450 | 4 900 | 3 | 127 483 | ||||
| 2017-06-26 | 2017-06-23 | 4 | Dispersyn Gerrit | RXII | Common stock, $0.0001 par value | D | 0,6200 | 3 500 | 2 | 3 500 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6200 | 5 000 | 3 | 122 583 | ||||
| 2017-06-22 | 2017-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6300 | 5 000 | 3 | 117 583 | ||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Series C Convertible Preferred Stock, $0.0001 par value | D | −332 499 | 0 | ||||||
| 2017-06-09 | 2017-06-09 | 4 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 332 499 | 1 150 312 | ||||||
| 2017-06-07 | 2017-06-06 | 4 | Freeman Jonathan E | RXII | Stock option (right to buy) | D | 0,54 | 3 500 | 3 500 | |||||
| 2017-04-26 | 2017-04-24 | 4 | Dispersyn Gerrit | RXII | Stock option (right to buy) | D | 0,65 | 95 000 | 95 000 | |||||
| 2017-04-26 | 2017-04-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6480 | 10 000 | 6 | 112 583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7655 | 15 | 0 | 102 583 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7651 | 665 | 1 | 102 568 | ||||
| 2017-03-20 | 2017-03-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7695 | 9 320 | 7 | 101 903 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 2 917 | 2 | 92 583 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6924 | 6 883 | 5 | 89 666 | ||||
| 2017-02-21 | 2017-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6915 | 200 | 0 | 82 783 | ||||
| 2017-02-08 | 2017-02-08 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6850 | 10 000 | 7 | 82 583 | ||||
| 2017-02-03 | 2017-02-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,63 | 13 000 | 13 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,63 | 7 000 | 7 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,63 | 2 500 | 2 500 | |||||
| 2017-02-03 | 2017-02-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,63 | 2 000 | 2 000 | |||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6968 | 9 700 | 7 | 72 583 | ||||
| 2017-01-26 | 2017-01-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6900 | 300 | 0 | 62 883 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6949 | 600 | 0 | 62 583 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6946 | 3 000 | 2 | 61 983 | ||||
| 2017-01-19 | 2017-01-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,6950 | 6 400 | 4 | 58 983 | ||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1 635 626 | ||||||||
| 2017-01-17 | 3 | Eliseev Alexey | RXII | Common stock, $0.0001 par value | D | 1 635 626 | ||||||||
| 2017-01-03 | 2016-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7260 | 2 000 | 1 | 52 583 | ||||
| 2016-12-27 | 2016-12-23 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,7190 | 3 000 | 2 | 4 500 | ||||
| 2016-12-23 | 2016-12-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7490 | 3 000 | 2 | 53 583 | ||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock warrant | D | 0,90 | 11 111 | 11 111 | |||||
| 2016-12-20 | 2016-12-16 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,9000 | 11 111 | 10 | 17 173 | ||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,90 | 33 333 | 33 333 | |||||
| 2016-12-20 | 2016-12-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,9000 | 33 333 | 30 | 50 583 | ||||
| 2016-02-12 | 2016-02-10 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,29 | 66 000 | 66 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,29 | 133 000 | 133 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,29 | 20 000 | 20 000 | |||||
| 2016-02-12 | 2016-02-10 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,29 | 16 666 | 16 666 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | −35 000 | 0 | |||||
| 2015-06-23 | 2015-06-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4550 | 35 000 | 16 | 172 500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock warrants | D | 0,52 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Overallotment purchase rights | D | 0,46 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37 500 | 15 | 44 000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Overallotment purchase right | I | 0,46 | 5 000 | 5 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock warrant | I | 0,52 | 5 000 | 5 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Overallotment purchase right | D | 0,46 | 35 000 | 35 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock warrant | D | 0,52 | 35 000 | 35 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT By spouse | RXII | Common stock, $0.0001 par value | I | 0,4000 | 10 000 | 4 | 15 000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,4000 | 70 000 | 28 | 137 500 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock warrant | D | 0,52 | 6 000 | 6 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Overallotment purchase right | D | 0,46 | 6 000 | 6 000 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12 000 | 5 | 13 000 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Overallotment purchase right | D | 0,46 | 6 250 | 6 250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock purchase warrant | D | 0,52 | 6 250 | 6 250 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Pavco Pamela | RXII | Common stock, $0.0001 par value | D | 0,4000 | 12 500 | 5 | 33 718 | ||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Overallotment purchase right | D | 0,46 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock warrant | D | 0,52 | 18 750 | 18 750 | |||||
| 2015-06-03 | 2015-06-02 | 4 | Dorman H. Paul | RXII | Common stock, $0.0001 par value | D | 0,4000 | 37 500 | 15 | 37 500 | ||||
| 2015-06-02 | 2015-06-01 | 4 | Pavco Pamela | RXII | Stock option (right to buy) | D | 0,38 | 66 000 | 66 000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | CAUWENBERGH GEERT | RXII | Stock option (right to buy) | D | 0,38 | 133 000 | 133 000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Bitterman Robert J | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Brownlie Keith L | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Lockshin Curtis | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Kontulis Caitlin | RXII | Stock option (right to buy) | D | 0,38 | 10 000 | 10 000 | |||||
| 2015-06-02 | 2015-06-01 | 4 | Dorman H. Paul | RXII | Stock option (right to buy) | D | 0,38 | 16 666 | 16 666 | |||||
| 2015-04-02 | 2015-04-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 0,7192 | 5 000 | 4 | 67 500 | ||||
| 2015-02-18 | 2015-02-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,1700 | 4 000 | 5 | 62 500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2499 | 1 156 | 1 | 58 500 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2400 | 644 | 1 | 57 344 | ||||
| 2015-02-11 | 2015-02-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,2200 | 200 | 0 | 56 700 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,1900 | 1 853 | 2 | 6 500 | ||||
| 2015-01-23 | 2015-01-22 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 1,2000 | 3 147 | 4 | 4 647 | ||||
| 2015-01-20 | 2015-01-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,0300 | 10 000 | 10 | 56 500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5893 | 500 | 1 | 46 500 | ||||
| 2014-12-31 | 2014-12-30 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 1,5867 | 2 000 | 3 | 46 000 | ||||
| 2014-10-14 | 2014-10-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 1,6799 | 3 000 | 5 | 44 000 | ||||
| 2014-09-23 | 2014-09-19 | 4 | CAUWENBERGH GEERT By child | RXII | Common stock, $0.0001 | I | 2,2000 | 4 500 | 10 | 4 500 | ||||
| 2014-09-16 | 2014-09-16 | 4 | CAUWENBERGH GEERT By Spouse | RXII | Common stock, $0.0001 par value | I | 2,0780 | 5 000 | 10 | 46 000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1900 | 2 000 | 4 | 41 000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1899 | 3 000 | 7 | 39 000 | ||||
| 2014-09-15 | 2014-09-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,1799 | 5 000 | 11 | 36 000 | ||||
| 2014-08-04 | 2014-07-31 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 2,4800 | 400 | 1 | 1 221 723 | ||||
| 2014-07-17 | 2014-07-15 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 2,5000 | 1 000 | 2 | 31 000 | ||||
| 2014-07-09 | 2014-07-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,5699 | 1 400 | 4 | 30 000 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8600 | 300 | 1 | 28 600 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8599 | 1 000 | 3 | 28 300 | ||||
| 2014-07-02 | 2014-07-02 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,8500 | 700 | 2 | 27 300 | ||||
| 2014-06-26 | 2014-06-25 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0100 | 500 | 2 | 26 600 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9600 | 800 | 2 | 26 100 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0000 | 200 | 1 | 25 300 | ||||
| 2014-06-19 | 2014-06-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9921 | 1 000 | 3 | 25 100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0499 | 800 | 2 | 24 100 | ||||
| 2014-06-09 | 2014-06-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0500 | 200 | 1 | 23 300 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9715 | 1 000 | 3 | 23 100 | ||||
| 2014-06-05 | 2014-06-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 2,9140 | 1 000 | 3 | 22 100 | ||||
| 2014-06-04 | 2014-06-02 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-06-04 | 2014-06-02 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 2,85 | 133 000 | 133 000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 2,85 | 66 000 | 66 000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 2,85 | 10 000 | 10 000 | |||||
| 2014-06-04 | 2014-06-02 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 2,85 | 16 666 | 16 666 | |||||
| 2014-05-15 | 2014-04-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,1100 | −5 000 | −21 | 1 250 315 | ||||
| 2014-03-26 | 2014-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | −2 000 | −12 | 1 255 315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | −1 941 | −11 | 1 257 315 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,7000 | −1 000 | −6 | 1 259 256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,6100 | −1 000 | −6 | 1 260 256 | ||||
| 2014-03-26 | 2014-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,5500 | −59 | −0 | 1 261 256 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | −1 400 | −9 | 1 261 315 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | −500 | −3 | 1 262 715 | ||||
| 2014-03-26 | 2014-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | −100 | −1 | 1 263 215 | ||||
| 2014-03-26 | 2014-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | −2 000 | −12 | 1 263 315 | ||||
| 2014-03-21 | 2014-02-28 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | −2 600 | −16 | 1 247 315 | ||||
| 2014-03-21 | 2014-02-27 | 4/A | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | −400 | −2 | 1 276 915 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,8000 | −2 000 | −12 | 1 265 315 | ||||
| 2014-03-11 | 2014-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,9100 | −2 000 | −12 | 1 267 315 | ||||
| 2014-03-11 | 2014-03-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1500 | −5 000 | −31 | 1 269 315 | ||||
| 2014-03-11 | 2014-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,2000 | 2 600 | 16 | 1 274 315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1000 | 400 | 2 | 1 276 915 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,1100 | −1 300 | −8 | 1 277 315 | ||||
| 2014-03-11 | 2014-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,4500 | −5 000 | −32 | 1 278 615 | ||||
| 2014-03-11 | 2014-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0300 | −400 | −2 | 1 283 615 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,5500 | −5 000 | −33 | 1 284 015 | ||||
| 2014-03-11 | 2014-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,0000 | −5 000 | −30 | 1 289 015 | ||||
| 2014-03-06 | 2014-02-24 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 6,3000 | −1 575 | −10 | 1 266 585 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,0000 | −5 000 | −25 | 1 268 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8500 | −5 000 | −24 | 1 273 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 5,1500 | −5 000 | −26 | 1 278 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,8000 | −576 | −3 | 1 283 160 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7100 | −2 100 | −10 | 1 283 736 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7350 | −2 900 | −14 | 1 285 836 | ||||
| 2014-03-06 | 2014-02-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7500 | −5 641 | −27 | 1 288 736 | ||||
| 2014-03-06 | 2014-02-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 4,7000 | −1 200 | −6 | 1 294 377 | ||||
| 2013-11-01 | 2013-10-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1900 | 800 | 3 | 21 100 | ||||
| 2013-11-01 | 2013-10-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,0900 | 200 | 1 | 20 300 | ||||
| 2013-10-24 | 2013-10-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3400 | 1 000 | 3 | 20 100 | ||||
| 2013-10-22 | 2013-10-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4300 | 300 | 1 | 19 100 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 200 | 1 | 18 800 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 18 600 | ||||
| 2013-10-22 | 2013-10-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,2900 | 100 | 0 | 18 500 | ||||
| 2013-10-16 | 2013-10-16 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5300 | 100 | 0 | 18 400 | ||||
| 2013-10-16 | 2013-10-15 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 18 300 | ||||
| 2013-10-16 | 2013-10-14 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5400 | 100 | 0 | 18 200 | ||||
| 2013-10-09 | 2013-10-09 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,1500 | 1 000 | 3 | 18 100 | ||||
| 2013-10-07 | 2013-10-04 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 200 | 1 | 17 100 | ||||
| 2013-10-07 | 2013-10-03 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5100 | 100 | 0 | 16 900 | ||||
| 2013-10-02 | 2013-09-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4200 | 300 | 1 | 16 800 | ||||
| 2013-09-26 | 2013-09-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 300 | 1 | 16 500 | ||||
| 2013-09-26 | 2013-09-24 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 100 | 0 | 16 200 | ||||
| 2013-09-24 | 2013-09-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4900 | 174 | 1 | 16 100 | ||||
| 2013-09-23 | 2013-09-20 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5200 | 326 | 1 | 15 926 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4800 | 100 | 0 | 15 600 | ||||
| 2013-09-19 | 2013-09-18 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5000 | 100 | 0 | 15 500 | ||||
| 2013-09-17 | 2013-09-17 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 15 400 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 15 200 | ||||
| 2013-09-16 | 2013-09-13 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 100 | 0 | 15 100 | ||||
| 2013-09-12 | 2013-09-11 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 150 | 1 | 15 000 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5800 | 150 | 1 | 14 850 | ||||
| 2013-09-12 | 2013-09-10 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 200 | 1 | 14 700 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3500 | 200 | 1 | 14 500 | ||||
| 2013-09-03 | 2013-08-30 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,3800 | 100 | 0 | 14 300 | ||||
| 2013-08-30 | 2013-08-29 | 4 | Lockshin Curtis | RXII | Common stock, $0.0001 par value | D | 3,7000 | 1 000 | 4 | 1 000 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,5500 | 200 | 1 | 14 200 | ||||
| 2013-08-30 | 2013-08-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,4000 | 200 | 1 | 14 000 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13 800 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6000 | 100 | 0 | 13 700 | ||||
| 2013-08-29 | 2013-08-28 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 13 600 | ||||
| 2013-08-28 | 2013-08-27 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7000 | 100 | 0 | 13 400 | ||||
| 2013-08-27 | 2013-08-26 | 4 | Bitterman Robert J | RXII | Common stock, $0.0001 par value | D | 3,9000 | 500 | 2 | 1 500 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6900 | 200 | 1 | 13 300 | ||||
| 2013-08-26 | 2013-08-23 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,7500 | 100 | 0 | 13 100 | ||||
| 2013-08-23 | 2013-08-22 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6200 | 300 | 1 | 13 000 | ||||
| 2013-08-22 | 2013-08-21 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8000 | 680 | 3 | 12 700 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7500 | 200 | 1 | 12 020 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,7000 | 200 | 1 | 11 820 | ||||
| 2013-08-21 | 2013-08-20 | 4 | CAUWENBERGH GEERT | RXII | Common Stock, $0.0001 par value | D | 3,9000 | 300 | 1 | 11 620 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6500 | 100 | 0 | 11 320 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,6700 | 120 | 0 | 11 220 | ||||
| 2013-08-20 | 2013-08-19 | 4 | CAUWENBERGH GEERT | RXII | Common stock, $0.0001 par value | D | 3,8600 | 100 | 0 | 11 100 | ||||
| 2013-08-06 | 2013-08-06 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0500 | 350 | 1 | 11 000 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0300 | 150 | 1 | 10 650 | ||||
| 2013-08-06 | 2013-08-05 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0000 | 500 | 2 | 10 500 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 100 | 0 | 1 000 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0200 | 100 | 0 | 900 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0100 | 100 | 0 | 800 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,0500 | 200 | 1 | 700 | ||||
| 2013-08-05 | 2013-08-05 | 4 | Bitterman Robert J | RXII | Common stock, par value $0.0001 | D | 4,1300 | 500 | 2 | 500 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,1000 | 500 | 2 | 9 833 | ||||
| 2013-07-31 | 2013-07-31 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,0200 | 167 | 1 | 10 000 | ||||
| 2013-07-31 | 2013-07-23 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1580 | −28 000 | −4 | 38 820 446 | ||||
| 2013-07-30 | 2013-07-29 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,5400 | 500 | 2 | 9 333 | ||||
| 2013-07-29 | 2013-07-26 | 4 | CAUWENBERGH GEERT | RXII | Common stock, par value $0.0001 | D | 4,8700 | 500 | 2 | 8 833 | ||||
| 2013-07-22 | 2013-07-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | −111 684 | −17 | 38 918 656 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1535 | −100 000 | −15 | 38 960 130 | ||||
| 2013-07-22 | 2013-07-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1525 | −100 000 | −15 | 39 060 130 | ||||
| 2013-07-22 | 2013-07-17 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | −100 000 | −16 | 39 160 130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | −95 000 | −19 | 39 260 130 | ||||
| 2013-07-15 | 2013-07-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1990 | −5 000 | −1 | 39 355 130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | −100 000 | −20 | 39 360 130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | −100 000 | −20 | 39 360 130 | ||||
| 2013-07-15 | 2013-07-10 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1960 | −30 000 | −6 | 39 560 130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | −18 180 | −4 | 39 590 130 | ||||
| 2013-07-08 | 2013-07-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | −100 000 | −19 | 39 608 310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1945 | −50 000 | −10 | 39 708 310 | ||||
| 2013-07-08 | 2013-07-03 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | −50 000 | −10 | 39 758 310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | −30 000 | −6 | 39 808 310 | ||||
| 2013-07-03 | 2013-07-02 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | −9 249 | −2 | 39 838 310 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1970 | −50 000 | −10 | 39 847 559 | ||||
| 2013-07-03 | 2013-07-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1965 | −50 000 | −10 | 39 897 559 | ||||
| 2013-07-02 | 2013-06-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | −46 874 | −9 | 39 947 559 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | −45 000 | −9 | 39 994 433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1930 | −60 000 | −12 | 40 039 433 | ||||
| 2013-07-02 | 2013-06-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | −50 000 | −10 | 40 099 433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1980 | −25 500 | −5 | 40 149 433 | ||||
| 2013-07-02 | 2013-06-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | −50 000 | −10 | 40 174 933 | ||||
| 2013-07-02 | 2013-06-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | −50 000 | −10 | 40 224 933 | ||||
| 2013-06-11 | 2013-06-07 | 4 | CAUWENBERGH GEERT | RXII | Stock Option (right to buy) | D | 0,20 | 4 000 000 | 4 000 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Pavco Pamela | RXII | Stock Option (right to buy) | D | 0,20 | 2 000 000 | 2 000 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Bitterman Robert J | RXII | Stock Option (right to buy) | D | 0,20 | 500 000 | 500 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Brownlie Keith L | RXII | Stock Option (right to buy) | D | 0,20 | 500 000 | 500 000 | |||||
| 2013-06-11 | 2013-06-07 | 4 | Kontulis Caitlin | RXII | Stock Option (right to buy) | D | 0,20 | 300 000 | 300 000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-05-03 | 2013-04-18 | 4/A | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-05-02 | 2013-05-02 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1905 | −253 000 | −48 | 32 393 095 | ||||
| 2013-05-02 | 2013-05-01 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,1925 | −659 500 | −127 | 32 646 095 | ||||
| 2013-05-02 | 2013-04-30 | 4 | Galena Biopharma, Inc. | RXII | Common Stock, $0.0001 par value | D | 0,2138 | −171 000 | −37 | 33 305 595 | ||||
| 2013-04-23 | 2013-03-18 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3480 | −52 900 | −18 | 39 831 365 | ||||
| 2013-04-23 | 2013-03-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3250 | −100 000 | −32 | 39 884 265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3310 | −126 843 | −42 | 39 984 265 | ||||
| 2013-04-23 | 2013-03-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3340 | −7 500 | −3 | 40 111 108 | ||||
| 2013-04-23 | 2013-03-12 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2720 | −100 000 | −27 | 40 118 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2730 | −100 000 | −27 | 40 218 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2210 | −100 000 | −22 | 40 318 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2400 | −100 000 | −24 | 40 418 608 | ||||
| 2013-04-23 | 2013-03-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2330 | −100 000 | −23 | 40 518 608 | ||||
| 2013-04-23 | 2013-03-08 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1940 | −50 000 | −10 | 40 618 608 | ||||
| 2013-04-23 | 2013-03-07 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1950 | −50 000 | −10 | 40 668 608 | ||||
| 2013-04-23 | 2013-03-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1490 | −36 570 | −5 | 40 718 608 | ||||
| 2013-04-23 | 2013-03-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1450 | −30 000 | −4 | 40 755 178 | ||||
| 2013-04-23 | 2013-03-04 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1450 | −50 000 | −7 | 40 785 178 | ||||
| 2013-04-23 | 2013-03-01 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 | D | 0,1500 | −20 000 | −3 | 40 835 178 | ||||
| 2013-04-23 | 2013-02-28 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | −200 | −0 | 40 855 178 | ||||
| 2013-04-23 | 2013-02-27 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | −29 888 | −5 | 40 855 378 | ||||
| 2013-04-23 | 2013-02-26 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1750 | −4 000 | −1 | 40 885 266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1820 | −8 000 | −1 | 40 889 266 | ||||
| 2013-04-23 | 2013-02-25 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1800 | −92 000 | −17 | 40 897 266 | ||||
| 2013-04-23 | 2013-02-22 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1600 | −40 000 | −6 | 40 989 266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1920 | −1 000 | −0 | 41 029 266 | ||||
| 2013-04-23 | 2013-02-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1900 | −49 000 | −9 | 41 030 266 | ||||
| 2013-04-23 | 2013-02-15 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1360 | −40 000 | −5 | 41 079 266 | ||||
| 2013-04-23 | 2013-02-14 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1160 | −30 000 | −3 | 41 119 266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0910 | −20 000 | −2 | 41 149 266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0950 | −20 000 | −2 | 41 169 266 | ||||
| 2013-04-23 | 2013-02-11 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,1150 | −40 000 | −5 | 41 189 266 | ||||
| 2013-04-23 | 2013-02-06 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0860 | −20 000 | −2 | 41 229 266 | ||||
| 2013-04-23 | 2013-02-05 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,0760 | −10 000 | −1 | 41 249 266 | ||||
| 2013-04-23 | 2013-03-21 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2320 | −48 500 | −11 | 39 684 265 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2310 | −57 100 | −13 | 39 732 765 | ||||
| 2013-04-23 | 2013-03-20 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,2550 | −1 500 | −0 | 39 789 865 | ||||
| 2013-04-23 | 2013-03-19 | 4 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 0,3000 | −40 000 | −12 | 39 791 365 | ||||
| 2013-04-22 | 2013-04-18 | 4 | Lockshin Curtis | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-04-22 | 2013-04-18 | 4 | Dorman H. Paul | RXII | Stock Option (right to buy) | D | 0,24 | 1 000 000 | 1 000 000 | |||||
| 2013-03-19 | 3 | Advanced RNA Technologies, LLC | RXII | Common Stock, $0.0001 par value | D | 41 259 266 | ||||||||
| 2013-03-13 | 3 | Opko Health, Inc. | RXII | Common Stock | D | 67 241 380 | ||||||||
| 2013-03-08 | 2013-03-06 | 4 | CAUWENBERGH GEERT | RXII | Common Stock | D | 0,1450 | 250 000 | 36 | 250 000 | ||||
| 2013-03-01 | 3 | Pavco Pamela | RXII | Common stock, par value $0.0001 | D | 90 153 | ||||||||
| 2013-03-01 | 3 | Galena Biopharma, Inc. | RXII | Common stock, $0.0001 par value | D | 33 476 595 | ||||||||
| 2013-03-01 | 3 | Kontulis Caitlin | RXII | Common stock, par value $0.0001 | D | 2 231 |
P
Köp på öppna marknaden eller privat köp av icke-derivatsäkerhet
S
Köp på öppna marknaden eller privat försäljning av icke-derivatsäkerhet
A
Bevilja, tilldelning eller annat förvärv av värdepapper från företaget (såsom en option)
C
Omvandling av derivat
D
Försäljning eller överföring av värdepapper tillbaka til företaget
F
Betalning av lösenpris eller skatteskuld med del av värdepapper som erhållits från bolaget
G
Överlåtelse av värdepapper från eller till insidern
K
Aktieswappar och liknande säkringsaffärer
M
Utövande eller omvandling av derivatsäkerhet som erhållits från företaget (som en option)
V
En transaktion friviligt rapporterad på schema 4
J
Andra (med en fotnot som beskriver transaktionen)
